28.69
Overview
News
Price History
Option Chain
Financials
Why SLP Down?
Discussions
Forecast
Stock Split
Dividend History
Simulations Plus Inc stock is traded at $28.69, with a volume of 52,563.
It is down -1.00% in the last 24 hours and down -15.99% over the past month.
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
See More
Previous Close:
$28.98
Open:
$28.97
24h Volume:
52,563
Relative Volume:
0.24
Market Cap:
$582.68M
Revenue:
$66.98M
Net Income/Loss:
$9.65M
P/E Ratio:
59.77
EPS:
0.48
Net Cash Flow:
$10.19M
1W Performance:
-7.60%
1M Performance:
-15.99%
6M Performance:
-17.25%
1Y Performance:
-30.88%
Simulations Plus Inc Stock (SLP) Company Profile
Name
Simulations Plus Inc
Sector
Industry
Phone
661-723-7723
Address
800 PARK OFFICES DRIVE, SUITE 401, RESEARCH TRIANGLE PARK, CA
Compare SLP with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
SLP
Simulations Plus Inc
|
28.69 | 582.68M | 66.98M | 9.65M | 10.19M | 0.48 |
![]()
VEEV
Veeva Systems Inc
|
220.91 | 35.98B | 2.66B | 665.91M | 1.08B | 4.05 |
![]()
SOLV
Solventum Corp
|
81.12 | 13.98B | 8.26B | 66.00M | 1.17B | 0.3682 |
![]()
DOCS
Doximity Inc
|
70.20 | 12.92B | 516.85M | 174.11M | 217.38M | 0.87 |
![]()
TEM
Tempus Ai Inc
|
53.06 | 9.36B | 640.44M | -743.28M | -206.93M | -11.29 |
![]()
HQY
Healthequity Inc
|
108.61 | 9.34B | 1.15B | 96.70M | -161.99M | 1.09 |
Simulations Plus Inc Stock (SLP) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Nov-15-24 | Initiated | Stephens | Overweight |
Jul-29-24 | Initiated | KeyBanc Capital Markets | Overweight |
Jul-16-24 | Initiated | JMP Securities | Mkt Perform |
Jun-28-24 | Initiated | William Blair | Outperform |
May-09-23 | Initiated | BTIG Research | Buy |
Oct-26-21 | Upgrade | Craig Hallum | Hold → Buy |
Jan-12-21 | Downgrade | Craig Hallum | Buy → Hold |
Oct-16-20 | Initiated | Raymond James | Outperform |
Sep-08-20 | Initiated | Oppenheimer | Outperform |
Jan-06-20 | Initiated | Craig Hallum | Buy |
View All
Simulations Plus Inc Stock (SLP) Latest News
(SLP) Investment Analysis and Advice - Stock Traders Daily
Simulations Plus, Inc. (NASDAQ:SLP) Given Average Rating of "Buy" by Analysts - MarketBeat
Simulations Plus (NASDAQ:SLP) stock falls 8.8% in past week as one-year earnings and shareholder returns continue downward trend - Simply Wall St
10,055 Shares in Simulations Plus, Inc. (NASDAQ:SLP) Acquired by Illumine Investment Management LLC - MarketBeat
Simulations Plus, Inc. (NASDAQ:SLP) Shares Could Be 30% Below Their Intrinsic Value Estimate - Yahoo Finance
Exclusive Report on Physical Property Prediction Services - openPR
Simulations Plus, Inc. (NASDAQ:SLP) Given Average Rating of “Buy” by Brokerages - Defense World
U.S. Computational Biology Market Size to Reach USD 9.85 Billion By 2033 - BioSpace
Biosimulation Market Next Big Thing | Major Giants- Genedata, Nuventra Pharma, Evidera - openPR
(SLP) On The My Stocks Page - Stock Traders Daily
Simulations Plus shareholders elect board, ratify auditor By Investing.com - Investing.com Canada
Simulations Plus shareholders elect board, ratify auditor - Investing.com
Simulations Plus (NASDAQ:SLP) Stock Passes Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Stephens Inc. AR Makes New $905,000 Investment in Simulations Plus, Inc. (NASDAQ:SLP) - MarketBeat
Simulations Plus (NASDAQ:SLP) Stock Price Passes Above 200-Day Moving Average – Should You Sell? - Defense World
US Growth Stocks With Insider Ownership As High As 25% - Simply Wall St
Fortive Q4 Earnings Beat Estimates, Revenues Increase Y/Y - Yahoo Finance
Why Investors Shouldn't Be Surprised By Simulations Plus, Inc.'s (NASDAQ:SLP) 29% Share Price Surge - Simply Wall St
Walter S. Woltosz Sells 20,000 Shares of Simulations Plus, Inc. (NASDAQ:SLP) Stock - MarketBeat
Conestoga Capital Advisors LLC Purchases 290,414 Shares of Simulations Plus, Inc. (NASDAQ:SLP) - MarketBeat
FUJIFILM's Q3 Earnings and Revenues Up Y/Y, Guidance Unchanged - Nasdaq
Simulations Plus, Inc. (NASDAQ:SLP) Short Interest Up 29.1% in January - MarketBeat
Insider Sell: Walter Woltosz Sells 20,000 Shares of Simulations Plus Inc (SLP) - GuruFocus.com
Simulations Plus to Participate in Upcoming Healthcare Investor Conferences - BioSpace
Biotech Leader Simulations Plus Sets Stage for Major Investor Showcase at Premier Healthcare Conferences - StockTitan
Badger Meter Q4 Earnings & Revenues Surpass Estimates, Stock Gains - Yahoo Finance
Q3 EPS Forecast for Simulations Plus Decreased by Analyst - MarketBeat
Q1 EPS Estimates for Simulations Plus Cut by William Blair - MarketBeat
Simulations Plus, Inc. (NASDAQ:SLP) Receives Average Recommendation of “Buy” from Analysts - Defense World
SG Americas Securities LLC Has $698,000 Stock Holdings in Simulations Plus, Inc. (NASDAQ:SLP) - Defense World
William Blair Issues Pessimistic Estimate for SLP Earnings - Defense World
Predicting Chiefs-Eagles Super Bowl 2025 winner in our Madden simulation, plus grading every coaching hire - CBS Sports
Biosimulation Market Growth, Drivers, and Opportunities - MarketsandMarkets
(SLP) Trading Advice - Stock Traders Daily
SAP's Q4 Earnings & Revenues Up Y/Y on Cloud Demand, 2025 View Updated - Yahoo Finance
KeyCorp Forecasts Strong Price Appreciation for Simulations Plus (NASDAQ:SLP) Stock - Defense World
Simulations Plus (NASDAQ:SLP) Price Target Raised to $37.00 - MarketBeat
Simulations Plus, Inc. (NASDAQ:SLP) Shares Acquired by Tributary Capital Management LLC - MarketBeat
JPMorgan Chase & Co. Boosts Stake in Simulations Plus, Inc. (NASDAQ:SLP) - Defense World
Simulations Plus, Inc. and Enabling Technologies Consortium Announce Strategic Collaboration to Advance GastroPlus®? Enhancements - Marketscreener.com
Simulations Plus and Enabling Technologies Consortium Announce Strategic Collaboration to Advance GastroPlus® Enhancements - Business Wire
Simulations Plus (SLP) to Report Q2 Earnings: What's in Store? - MSN
World Bank warns that US tariffs could reduce global growth outlook -January 16, 2025 at 01:03 pm EST - Marketscreener.com
There May Be Reason For Hope In Simulations Plus' (NASDAQ:SLP) Disappointing Earnings - Yahoo Finance
Simulations Plus Inc (SLP) Stock Price Down 3.84% on Jan 14 - GuruFocus.com
Barclays PLC Has $911,000 Holdings in Simulations Plus, Inc. (NASDAQ:SLP) - Defense World
Barclays PLC Grows Stock Holdings in Simulations Plus, Inc. (NASDAQ:SLP) - MarketBeat
Exploring High Growth Tech Stocks in the US Market - Simply Wall St
Simulations Plus Supported Development of Majority of FDA-Approved Drugs in 2024 - Business Wire
Simulations Plus Inc Stock (SLP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Simulations Plus Inc Stock (SLP) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
WOLTOSZ WALTER S | Director |
Jan 02 '25 |
Sale |
27.88 |
20,000 |
557,662 |
3,422,584 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):